31470514|t|Anti-Diabetic Countermeasures Against Tobacco Smoke-Dependent Cerebrovascular Toxicity: Use and Effect of Rosiglitazone.
31470514|a|Tobacco smoking (TS) is one of the most addictive habit sand a main public health hazards, impacting the vascular endothelium through oxidative stress (OS) stimuli, exposure to nicotine, and smoking-induced inflammation in a dose-dependent manner. Increasing evidence also suggested that TS increases glucose intolerance and the risk factor of developing type-2 diabetes mellitus (2DM), which, along with TS, is connected to blood-brain barrier (BBB) injuries, and heightens the risk of cerebrovascular disorders. Although the exact mechanism of rosiglitazone (RSG) is unknown, our previous in vitro work showed how RSG, an oral anti-diabetic drug belonging to the family of thiazolidinedione class, can protect BBB integrity through enhancement of nuclear factor erythroid 2-related factor (Nrf2) activity. Herein, we have validated the protective role of rosiglitazone against TS-induced BBB impairment in vivo. Our results revealed that RSG as a peroxisome proliferator-activated receptor gamma (PPARgamma), activates counteractive mechanisms primarily associated with the upregulation of Nrf2 and PPARgamma pathways which reduce TS-dependent toxicity at the cerebrovascular level. In line with these findings, our results show that RSG reduces inflammation and protects BBB integrity. In conclusion, RSG offers a novel and promising therapeutic application to reduce TS-induced cerebrovascular dysfunction through activation of the PPARgamma-dependent and/or PPARgamma-independent Nrf2 pathway.
31470514	0	13	Anti-Diabetic	Disease	MESH:D003920
31470514	38	51	Tobacco Smoke	Species	
31470514	62	86	Cerebrovascular Toxicity	Disease	MESH:D002561
31470514	106	119	Rosiglitazone	Chemical	MESH:D000077154
31470514	121	136	Tobacco smoking	Species	
31470514	138	140	TS	Species	671417
31470514	298	306	nicotine	Chemical	MESH:D009538
31470514	328	340	inflammation	Disease	MESH:D007249
31470514	409	411	TS	Species	671417
31470514	422	429	glucose	Disease	MESH:D018149
31470514	476	500	type-2 diabetes mellitus	Disease	MESH:D003924
31470514	502	505	2DM	Disease	MESH:D003924
31470514	526	528	TS	Species	671417
31470514	551	580	-brain barrier (BBB) injuries	Disease	MESH:C536830
31470514	608	633	cerebrovascular disorders	Disease	MESH:D002561
31470514	667	680	rosiglitazone	Chemical	MESH:D000077154
31470514	682	685	RSG	Chemical	MESH:D000077154
31470514	737	740	RSG	Chemical	MESH:D000077154
31470514	750	763	anti-diabetic	Disease	MESH:D003920
31470514	796	813	thiazolidinedione	Chemical	MESH:C089946
31470514	978	991	rosiglitazone	Chemical	MESH:D000077154
31470514	1000	1002	TS	Species	671417
31470514	1011	1025	BBB impairment	Disease	MESH:C536830
31470514	1061	1064	RSG	Chemical	MESH:D000077154
31470514	1254	1256	TS	Species	671417
31470514	1267	1275	toxicity	Disease	MESH:D064420
31470514	1357	1360	RSG	Chemical	MESH:D000077154
31470514	1369	1381	inflammation	Disease	MESH:D007249
31470514	1425	1428	RSG	Chemical	MESH:D000077154
31470514	1492	1494	TS	Species	671417
31470514	1503	1530	cerebrovascular dysfunction	Disease	MESH:D002561
31470514	Negative_Correlation	MESH:D000077154	MESH:D007249
31470514	Negative_Correlation	MESH:D000077154	MESH:D002561
31470514	Negative_Correlation	MESH:D000077154	MESH:D064420
31470514	Negative_Correlation	MESH:D000077154	MESH:D003920
31470514	Negative_Correlation	MESH:C089946	MESH:D003920
31470514	Negative_Correlation	MESH:D000077154	MESH:C536830

